Skip to main content

Market Research Outlook

MRO Tracker · Pharma

Warning letters issued by the US FDA to Indian drug plants and testing labs in 2026, with site, letter number and the main issue. The list covers letters for drug manufacturing quality. It is a verified running log rather than a complete count: the FDA issued more letters to Indian sites over its fiscal year, and further letters are added as each one is checked.

14letters to Indian sites verified so far in 2026
5to API makers
8sites also on import alert
2contract testing labs
MRO View: API makers and testing labs make up half of the 2026 list, and eight sites were placed on import alert before or alongside the letter. The import alert is what stops shipments at the US border, while the letter can hold back new approvals from the site until it is closed.

Warning letters to Indian sites, 2026

IssuedCompanySiteLetter no.Key detail
27 Oct 2026Pritam InternationalBhagwanpur, Haridwar, Uttarakhand320-27-12OTC toothpaste contract maker; on Import Alert 66-40 since 3 Sep 2026
18 Aug 2026Reliance Life SciencesRabale, Navi Mumbai, Maharashtra320-26-117Sterile products; inspected 19 to 27 Feb 2026; on Import Alert 66-40 since 9 Jul 2026
18 Aug 2026Shoolin Pharma ChemIndrad, Mehsana, Gujarat320-26-116API maker; inspected 13 to 17 Apr 2026; on Import Alert 66-40 since 11 Aug 2026
13 Aug 2026Eugia Pharma Specialities (Aurobindo), Unit 1Kolthur, Telangana320-26-115Sterile injectables; inspected 16 to 27 Feb 2026
12 Aug 2026Auriga Research (contract testing lab)Yeshwanthpur, Bengaluru, Karnataka320-26-113Inspected 4 to 6 Feb 2026; repeat testing until results passed
24 Jul 2026Dabur IndiaSaily, Silvassa, DNH and DD320-26-105OTC drugs; inspected 12 to 16 Jan 2026; on Import Alert 66-40 since 10 Jun 2026 (company filing)
13 Jul 2026Almon HealthcareBavala, Ahmedabad, Gujarat320-26-102API maker; inspected 9 to 13 Feb 2026; on Import Alert 66-40 since 9 Jun 2026
13 Jul 2026Shimoga ChemicalsKupwad MIDC, Sangli, Maharashtra320-26-101API maker; inspected 19 to 23 Jan 2026; on Import Alert 66-40 since 2 Jun 2026
2 Jun 2026Zydus LifesciencesBaddi, Himachal Pradesh320-26-92Finished dosage plant; incoming component testing failures
21 May 2026Alchymars ICM SMAlathur, Tamil Nadu320-26-77API maker; unannounced inspection Nov to Dec 2025; on Import Alert 66-40 since 19 May 2026
30 Mar 2026Intas PharmaceuticalsSelaqui, Dehradun, Uttarakhand320-26-57Inspected 8 to 17 Sep 2025; weak handling of out of specification assay results
11 Mar 2026Flowchem PharmaHindupur, Andhra Pradesh320-26-51API maker; inspected 8 to 12 Sep 2025; on Import Alert 66-40 since 22 Jan 2026
3 Mar 2026Tentamus India (contract testing lab)Kompally, Hyderabad, Telangana320-26-47Quality control unit failures
30 Jan 2026Cohance LifesciencesIDA Nacharam, Medchal Malkajgiri, Telangana320-26-40Tablets and capsules; inspected 4 to 12 Aug 2025; cleaning and investigation failures

Letters to companies that only market or import products, and letters on clinical or laboratory study conduct, are not included.

Need the numbers behind this tracker?

We assess compliance history and supply risk for API and formulation sourcing decisions.

Get the monthly India tracker updateNew state data and new plant announcements in one short email, once a month.

One email a month. Reply to any email to unsubscribe. Privacy policy